Drugs & Targets NHS England will wait to consider NHS rollout of Galleri multi-cancer early detection test May 31, 2024Vol.50 No.22
Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials April 12, 2024Vol.50 No.15By Jacquelyn Cobb
Regulatory News Heated discussion breaks out in recent meeting as FDA mulls standards for MCD approvalMeanwhile, NCI trial will assess clinical utility January 12, 2024Vol.50 No.02By Jacquelyn Cobb
Clinical Roundup GRAIL presents PATHFINDER multi-cancer early detection screening study results September 16, 2022Vol.48 No.33
